Reversal of long-term dendritic spine alterations in Alzheimer disease models
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Synapse loss is strongly correlated with cognitive impairment in Alzheimer's disease (AD). We have previously reported the loss of dendritic spines and the presence of dystrophic neurites in both the hippocampi of transgenic mice overexpressing amyloid precursor protein (APP) and in the human brain affected with AD. In the studies reported here we have asked whether the acute alterations in dendritic spines induced by Aβ, as well as the chronic loss of spine density seen in hAPP transgenic mice, are reversible by treatments that restore the cAMP/PKA/CREB signaling pathway or proteasome function to control levels. The results show that both rolipram and TAT-HA-Uch-L1 restore spine density to near control conditions, even in elderly mice. The results suggest that changes in dendritic structure and function that occur after Aβ elevation are reversible even after long periods of time, and that one could envision therapeutic approaches to AD based on this restoration that could work independently of therapies aimed at lowering Aβ levels in the brain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, at least some evidence suggests structural and functional alterations may be reversible pharmacologically, opening new therapeutic directions in Alzheimer’s disease98.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [98]
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 3×
“Terry RD, et al. (1991) Physical basis of cognitive alterations in Alzheimer’s disease: Synapse loss is the major correlate of cognitive impairment.”
BackgroundCorrelative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · cited 2×
“Double transgenic APP/PS1 mice were obtained by crossing hemizygous transgenic mice (HuAPP695SWE; line tg2576) expressing mutant human APP K670N, M671L (35) with hemizygous PS1 mice that express mutant human PS1M146V (line 6.2) (36).”
BackgroundInfluentialPathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052 · cited 2×
“The changes confirm our earlier studies showing similar changes in both J20 single transgenic and APP/PS1 double transgenic animals and in human AD brain (1).”
BackgroundResultAlzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · cited 1×
“The development of A plaques has been successfully achieved in transgenic mice overexpressing mutated forms of APP (4) and is greatly accelerated in transgenic models overexpressing mutated forms of both APP and PS1 (5).”
BackgroundWolfe, M. S., Xia, W., Ostaszewski, B. L., Diehl, T. S., Kimberly, W. T., & Selkoe, D. J. (1999) · Nature · doi:10.1038/19077 · Cited by 1,916
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Matsuzaki, M., Ellis-Davies, G. C. R., Nemoto, T., Miyashita, Y., Iino, M., & Kasai, H. (2001) · Nature Neuroscience · doi:10.1038/nn736 · Cited by 1,802
Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592 · cited 1×
“Dendritic spine loss is also seen in the brains of PDAPP, Tg2576, and J20 APP transgenic mice (27, 28) and in hippocampal slices treated with A (29, 30).”
BackgroundIncreased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Perez-tur, J., Hutton, M., Buee, L., Harigaya, Y., Yager, D., et al. (1996) · Nature · doi:10.1038/383710a0 · Cited by 1,465
Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability
Dahlgren, K. N., Manelli, A. M., Stine, W. B., Baker, L. K., Krafft, G. A., & LaDu, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201750200 · Cited by 1,452
Holcomb, L., Gordon, M. N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-097 · Cited by 1,386 · cited 2×
“Transgenic mice were genotyped by polymerase chain reaction (PCR) using oligonucleotides for human APP and PS1 together with PuRe TaqPCR beads (Amersham 27–9559-01).”
BackgroundStructure and function of dendritic spines
Nimchinsky, E. A., Sabatini, B. L., & Svoboda, K. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.081501.160008 · Cited by 1,208 · cited 3×
“Similar results have since been reported by several other groups (28, 31–33) Over the past several years, A has been demonstrated to inhibit hippocampal long-term potentiation (LTP) and activation of the PKA/CREB pathway in both cultured neurons and murine hippocampal slices (19).”
BackgroundMethodResultInfluentialLacor, P. N., Buniel, M. C., Furlow, P. W., Sanz Clemente, A., Velasco, P. T., Wood, M., Viola, K. L., & Klein, W. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3501-06.2007 · Cited by 1,188
Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123
AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss
Hsieh, H., Boehm, J., Sato, C., Iwatsubo, T., Tomita, T., Sisodia, S., & Malinow, R. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.035 · Cited by 1,042
Cell Type and Pathway Dependence of Synaptic AMPA Receptor Number and Variability in the Hippocampus
Nusser, Z., Lujan, R., Laube, G., Roberts, J. D. B., Molnar, E., & Somogyi, P. (1998) · Neuron · doi:10.1016/s0896-6273(00)80565-6 · Cited by 804
Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease
Jacobsen, J. S., Wu, C.-C., Redwine, J. M., Comery, T. A., Arias, R., Bowlby, M., Martone, R., Morrison, J. H., Pangalos, M. N., Reinhart, P. H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600948103 · Cited by 701
Inactivity produces increases in neurotransmitter release and synapse size
Murthy, V. N., Schikorski, T., Stevens, C. F., & Zhu, Y. (2001) · Neuron · doi:10.1016/s0896-6273(01)00500-1 · Cited by 612
Critical periods for experience-dependent synaptic scaling in visual cortex
Desai, N. S., Cudmore, R. H., Nelson, S. B., & Turrigiano, G. G. (2002) · Nature Neuroscience · doi:10.1038/nn878 · Cited by 582 · cited 1×
“This phenomenon postulates that the total strength of synaptic output to a given neuron is conserved so that the neuronal output is buffered against disturbances (39).”
BackgroundMUTANT GENES IN FAMILIAL ALZHEIMER'S DISEASE AND TRANSGENIC MODELS
Price, D. L., & Sisodia, S. S. (1998) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.21.1.479 · Cited by 572 · cited 1×
“The molecular pathological hallmarks of AD are intracellular neurofibrillary tangles and extracellular amyloid (A ) plaques (2).”
BackgroundFibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches
Tsai, J., Grutzendler, J., Duff, K., & Gan, W.-B. (2004) · Nature Neuroscience · doi:10.1038/nn1335 · Cited by 561
Spires, T. L., Meyer-Luehmann, M., Stern, E. A., McLean, P. J., Skoch, J., Nguyen, P. T., Bacskai, B. J., & Hyman, B. T. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1879-05.2005 · Cited by 550
Vitolo, O. V., Sant'Angelo, A., Costanzo, V., Battaglia, F., Arancio, O., & Shelanski, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172504199 · Cited by 534
Self-citationGong, B., Vitolo, O. V., Trinchese, F., Liu, S., Shelanski, M., & Arancio, O. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22831 · Cited by 442 · cited 1×
“APP/PS1 mice display impaired LTP, spatial working memory, and contextual learning as early as 3–4 months of age, and they show deficits in basal synaptic transmission (BST) and spatial reference memory after 5–6 months of age (6).”
BackgroundSelf-citationGong, B., Cao, Z., Zheng, P., Vitolo, O. V., Liu, S., Staniszewski, A., Moolman, D., Zhang, H., Shelanski, M., & Arancio, O. (2006) · Cell · doi:10.1016/j.cell.2006.06.046 · Cited by 420
Self-citationMulticolor “DiOlistic” Labeling of the Nervous System Using Lipophilic Dye Combinations
Gan, W.-B., Grutzendler, J., Wong, W. T., Wong, R. O. L., & Lichtman, J. W. (2000) · Neuron · doi:10.1016/s0896-6273(00)00031-3 · Cited by 331
Portera-Cailliau, C., Pan, D. T., & Yuste, R. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-18-07129.2003 · Cited by 269 · cited 1×
“Longer spines have synapses that are less mature and more modifiable (23, 24).”
BackgroundMajewska, A., Brown, E., Ross, J., & Yuste, R. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-05-01722.2000 · Cited by 248 · cited 1×
“Longer spines have synapses that are less mature and more modifiable (23, 24).”
BackgroundDendrite and dendritic spine alterations in alzheimer models
Moolman, D. L., Vitolo, O. V., Vonsattel, J.-P. G., & Shelanski, M. L. (2004) · Journal of Neurocytology · doi:10.1023/b:neur.0000044197.83514.64 · Cited by 245 · cited 2×
“Numerous changes in dendritic architecture have been observed, including loss of dendritic spines in transgenic mice overexpressing APP and in the brains of persons dying of AD (27).”
BackgroundSelf-citationBlock of LTP in rat hippocampus in vivo by β-amyloid precursor protein fragments
Cullen, W. K., Suh, Y.-H., Anwyl, R., & Rowan, M. J. (1997) · NeuroReport · doi:10.1097/00001756-199710200-00006 · Cited by 235
Lanz, T. A., Carter, D. B., & Merchant, K. M. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00079-2 · Cited by 227 · cited 1×
“Dendritic spine loss is also seen in the brains of PDAPP, Tg2576, and J20 APP transgenic mice (27, 28) and in hippocampal slices treated with A (29, 30).”
BackgroundGonatas, N. K., Anderson, W., & Evangelista, I. (1967) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-196701000-00003 · Cited by 186 · cited 1×
“Human studies have shown significant synaptic pathology in AD (7, 8) and have identified synapse loss as a major correlate of cognitive impairment in the disease (9).”
Background(1995) · PubMed · Cited by 167
Freir, D. B., Holscher, C., & Herron, C. E. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.85.2.708 · Cited by 153
Dendrites, dementia and the down syndrome
Takashima, S., Ieshima, A., Nakamura, H., & Becker, L. E. (1989) · Brain and Development · doi:10.1016/s0387-7604(89)80082-8 · Cited by 150 · cited 1×
“Examination of post mortem brains from AD patients has shown a loss of dendritic spines (25, 26).”
BackgroundImpairments of long-term potentiation in hippocampal slices of β-amyloid-infused rats
Itoh, A., Akaike, T., Sokabe, M., Nitta, A., Iida, R., Olariu, A., Yamada, K., & Nabeshima, T. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00601-9 · Cited by 129
Wu, C.-C., Chawla, F., Games, D., Rydel, R. E., Freedman, S., Schenk, D., Young, W. G., Morrison, J. H., & Bloom, F. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402147101 · Cited by 89 · cited 2×
“In APP transgenic mice, one of the earliest morphological changes is a reduction of hippocampal volume because of a loss of dendritic mass (14).”
BackgroundAmyloid β peptide adversely affects spine number and motility in hippocampal neurons
Shrestha, B. R., Vitolo, O. V., Joshi, P., Lordkipanidze, T., Shelanski, M., & Dunaevsky, A. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.07.011 · Cited by 88 · cited 2×
“Dendritic spine loss is also seen in the brains of PDAPP, Tg2576, and J20 APP transgenic mice (27, 28) and in hippocampal slices treated with A (29, 30).”
BackgroundSelf-citationAlpár, A., Ueberham, U., Brückner, M. K., Seeger, G., Arendt, T., & Gärtner, U. (2006) · Brain Research · doi:10.1016/j.brainres.2006.04.109 · Cited by 74
Gertz, H., Cervós‐Navarro, J., & Ewald, V. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90720-8 · Cited by 53 · cited 1×
“Examination of post mortem brains from AD patients has shown a loss of dendritic spines (25, 26).”
BackgroundNeocortical synapses in a presenile dementia.
Gonatas, N. K. (1967) · PubMed · Cited by 9
Cited by
Dendritic spine pathology in neuropsychiatric disorders
Penzes, P., Cahill, M. E., Jones, K. A., VanLeeuwen, J.-E., & Woolfrey, K. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2741 · Cited by 1,523
Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases
Park, S.-J., Ahmad, F., Philp, A., Baar, K., Williams, T., Luo, H., Ke, H., Rehmann, H., Taussig, R., Brown, A. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.017 · Cited by 1,349
Hoover, B. R., Reed, M. N., Su, J., Penrod, R. D., Kotilinek, L. A., Grant, M. K., Pitstick, R., Carlson, G. A., Lanier, L. M., Yuan, L.-L., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.030 · Cited by 1,118
“Our growing appreciation for the effects of other dementia-related proteins on dendritic spines (Davies et al., 1987; Selkoe, 2002; Hsieh et al., 2006; Kramer and Schulz-Schaeffer, 2007; Fuhrmann et al., 2007; Knobloch and Mansuy, 2008; Smith et al., 2009) highlights the importance of dendritic spines as a locus in wh…”
BackgroundResultInfluentialExtrasynaptic NMDA Receptor Involvement in Central Nervous System Disorders
Parsons, M. P., & Raymond, L. A. (2014) · Neuron · doi:10.1016/j.neuron.2014.03.030 · Cited by 553
“When applied to cultured cortical neurons, Ab enhances NMDAR endocytosis and decreases synaptic expression (Snyder et al., 2005), consistent with the finding that calcium influx through NMDARs after glutamate uncaging at single spines is significantly reduced after Ab treatment (Shankar et al.”
InfluentialThe role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease
Amidfar, M., de Oliveira, J., Kucharska, E., Budni, J., & Kim, Y.-K. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118020 · Cited by 410
Metadata
- Authors
- Smith, D. L., Pozueta, J., Gong, B., Arancio, O., & Shelanski, M.
- Affiliations
- Columbia University (US)
- Guy's Hospital (GB)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-09-29
- Volume
- 106
- Issue
- 39
- Pages
- 16877-16882
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2743726
- OpenAlex
- W1977390447
- Cited by
- 229
- References
- 42
- Citations by year
- 2026: 1 · 2025: 10 · 2024: 7 · 2023: 9 · 2022: 6 · 2021: 7 · 2020: 21 · 2019: 10 · 2018: 16 · 2017: 20 · 2016: 10 · 2015: 17 · 2014: 22 · 2013: 18 · 2012: 23
- FWCI
- 12.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (AG 008700)
- National Institute of Neurological Disorders and Stroke (NS15076, R01NS015076)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, dendritic spines, synaptic loss, amyloid-beta, APP transgenic mice, rolipram, cAMP/PKA/CREB signaling, proteasome function, UCHL1, dystrophic neurites, hippocampus, cognitive impairment
- MeSH terms
- Alzheimer Disease, Animals, Brain, Dendrites, Disease Models, Animal, Hippocampus, Humans, Mice, Transgenic, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Dendritic Spines, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.